Entry Detail



General Information

Database ID:exR0005388
RNA Name:FTL
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):48965309End Site(bp):48966879
External Links:ENSG00000087086



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC027644.4
chr7
66628958
66811189
+
AC093525.2
chr16
2496032
2520218
+
AAGAB
chr15
67200667
67255195
-
AL136454.1
chr1
192716132
192716653
+
AC004922.1
chr7
99325879
99394653
+
AGPAT2
chr9
136673143
136687457
-
AC018523.2
chr11
14493783
14520344
-
AKIRIN2
chr6
87674860
87702233
-
AC008763.3
chr19
7678501
7682854
+
AK4
chr1
65147549
65232145
+
ACLY
chr17
41866917
41930542
-
AC138969.1
chr16
16317444
16350590
+
ADPRH
chr3
119579268
119589945
+
AC004997.1
chr22
30285238
30299482
-
AC069503.2
chr12
121888809
121921470
+
AKAP8L
chr19
15380050
15419141
-
ACTR3
chr2
113890063
113962596
+
AC005258.1
chr19
2269525
2341172
+
ALDH3A2
chr17
19648136
19685760
+
AIP
chr11
67483026
67491103
+
AIF1L
chr9
131096476
131123152
+
AIFM2
chr10
70098223
70132934
-
ACBD6
chr1
180269653
180502954
-
ACTB
chr7
5527148
5563784
-
ACTR8
chr3
53867066
53882152
-
ABHD8
chr19
17292131
17310236
-
AC105052.3
chr7
102637049
102671641
-
ACP1
chr2
264140
278283
+
ADGRA3
chr4
22345071
22516066
-
ADD3
chr10
109996368
110135565
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-639
chr19
14529603
14529625
+
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002467.1
chr7
107739999
107744581
-
AC004687.1
chr17
58330884
58332508
-
AC005696.1
chr17
2712309
2712833
+
AC006504.5
chr19
27793431
27984984
+
AC007114.1
chr17
57071814
57085024
-
AC007952.4
chr17
19112000
19112636
-
AC009908.1
chr8
124996985
124998198
-
AC010327.5
chr19
55216660
55221616
+
AC016876.2
chr17
7581964
7584086
-
AC021078.1
chr5
149494314
149504670
-
AC026362.1
chr12
122975320
122982907
+
AC079174.2
chr12
106250759
106252786
+
AC118553.1
chr1
99968383
99969864
-
AD000090.1
chr19
35557956
35581954
+
AL022157.1
chrX
57121662
57127243
+
AL022311.1
chr22
37876148
37895563
+
AL033527.3
chr1
39788976
39790171
+
AL137230.2
chr14
89628921
89642671
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.